Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
06/2000
06/20/2000US6077676 Single-chain polypeptides comprising troponin I and troponin C
06/20/2000US6077675 Drug screening by contacting compound with recombinant cell which expresses a nucleic acid encoding the receptor and monitoring for binding or modulation of receptor; anticonvulsants; analgesics; cognition enhancers
06/20/2000US6077674 Coupling linking agent to end of full-length oligonucleotides in mixture of variable length synthesized oligonucleotides, cleaving other end from support, depositing mixture on surface, linking group preferentially attaches to surface
06/20/2000US6077672 Antisense modulation of TRADD expression
06/20/2000US6077670 Fluorescent material labeled-probe and method for detecting hybridization
06/20/2000US6077669 Exposing sample to dry binding partner of target analyte causing hydration of binding partner, then exposing to another reagent or condition which if target is present in the sample, its amount will change; reduction in interference
06/20/2000US6077668 Highly sensitive multimeric nucleic acid probes
06/20/2000US6077667 Method for chromosomal rearrangement by consecutive gene targeting of two recombination substrates to the deletion endpoints
06/20/2000US6077666 Receptor identification method
06/20/2000US6077664 Thermophilic DNA polymerases from Thermotoga neapolitana
06/20/2000US6077663 Composition for introducing nucleic acid complexes into higher eucaryotic cells
06/20/2000US6077518 Cloning of mite allergens
06/20/2000US6077517 House dust mite allergen, Der p VII, and uses thereof
06/20/2000US6077511 Antigenic peptide derived from the G protein of RSV for type- and subtype-specific diagnosis of respiratory syncytial virus (RSV) infection
06/20/2000US6077510 Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases
06/20/2000US6077508 Administering a labeled molecule such as antibody that binds to a urokinase plasminogen activator receptor; delaying to allow labeled molecule to concentrate at metastatic lesion; detection above background level indicates metastatic lesion
06/20/2000US6076301 Solid matrix priming of seeds with microorganisms and selected chemical treatment
06/20/2000CA2186875C Gene imparting flocculability to yeast and gene product
06/20/2000CA2091236C Ornithine carbamoyl transferase gene and utilization of the dna
06/20/2000CA2089377C Novel nucleoside analogs
06/20/2000CA2080924C Endo-1,4-beta-glucanase genes and their use in plants
06/20/2000CA2001303C Endothelin dna and use thereof
06/20/2000CA1341033C Precursor protein of apc polypeptide, dna coding for this, and diagnostic use of the dna and of the protein
06/15/2000WO2000034791A1 Assays for compounds which increase phospholipase a2 activity
06/15/2000WO2000034789A2 Method for determining asthma susceptibility
06/15/2000WO2000034784A1 Protein scaffolds for antibody mimics and other binding proteins
06/15/2000WO2000034782A1 Flint compositions and uses thereof
06/15/2000WO2000034780A2 METHODS AND COMPOSITIONS USEFUL FOR TARGETING ACTIVATED VITRONECTIN RECEPTOR αvβ¿3?
06/15/2000WO2000034652A2 Methods of identifying point mutations in a genome
06/15/2000WO2000034529A1 Complete genome sequence of a simian immunodeficiency virus from a red-capped mangabey
06/15/2000WO2000034526A1 Fluorescent proteins from non-bioluminescent species of class anthozoa, genes encoding such proteins and uses thereof
06/15/2000WO2000034518A1 Array and method for analysing nucleic acid sequences
06/15/2000WO2000034516A1 Detection of rantes gene promotor polymorphisms
06/15/2000WO2000034515A1 Use of factor x polymorphism in the diagnosis and treatment of factor x and/or factor xa mediated diseases
06/15/2000WO2000034513A1 METHOD FOR DETECTING IN VITRO A TARGET SUBSTANCE IN A SAMPLE COMPRISING THE LABELLING OF SAID SUBSTANCE WITH A REPORTER GENE AND THE SEQUENCES REQUIRED FOR EXPRESSING SAID REPORTER GENE $i(IN VITRO)
06/15/2000WO2000034512A1 Method for detecting and/or quantifying a known function from a nucleic acid sample
06/15/2000WO2000034511A2 Aβ-PEPTIDE SCREENING ASSAY
06/15/2000WO2000034505A1 Expression system for factor viii
06/15/2000WO2000034504A2 Method of protein removal
06/15/2000WO2000034500A2 Methods for increasing the efficiency of gene transfer
06/15/2000WO2000034499A1 Use of an immuno complex for the preparation of a therapeutic composition useful for transfecting a polynucleotide into macropinocyte cells
06/15/2000WO2000034498A1 Two-step immunization procedure against chlamydia infection
06/15/2000WO2000034497A2 Enhanced packaging of herpes virus amplicons and generation of recombinant virus vectors
06/15/2000WO2000034496A2 Use of trans-activation and cis-activation to modulate the persistence of expression of a transgene
06/15/2000WO2000034495A2 A method of genetically modifying very primitive quiescent human hematopoietic stem cells
06/15/2000WO2000034494A1 A recombinant vector expressing multiple costimulatory molecules and uses thereof
06/15/2000WO2000034493A2 Regulatory sequences of the mouse villin gene - use in transgenesis
06/15/2000WO2000034492A1 Regulatory sequences of the mouse villin gene - use in transgenesis
06/15/2000WO2000034491A2 An improved efficiency agrobacterium-mediated plant transformation method
06/15/2000WO2000034490A1 A method for manufacturing glycoproteins having human-type glycosylation
06/15/2000WO2000034489A1 Major basic protein deficient animals
06/15/2000WO2000034487A1 STREPTOCOCCAL C5a PEPTIDASE VACCINE
06/15/2000WO2000034486A1 Human secretory phospholipase a¿2?
06/15/2000WO2000034485A2 Beta-1,3-galactosyltransferase homologs
06/15/2000WO2000034484A1 Polymorphic loci that differentiate escherichia coli 0157:h7 from other strains
06/15/2000WO2000034483A2 Compounds and methods for treatment and diagnosis of chlamydial infection
06/15/2000WO2000034482A2 Novel compounds derived from neisseria meningitidis
06/15/2000WO2000034481A2 DRUG TARGETS IN $i(CANDIDA ALBICANS)
06/15/2000WO2000034480A1 Polypeptides and polynucleotides 'basb040' from neisseria meningitidis and vaccine comprising said polypeptides and polynucleotides
06/15/2000WO2000034479A1 Genes of resistance against diseases induced by microorganism belonging to magnapothe grisea, plants transformed by the genes and process for producing the same
06/15/2000WO2000034478A1 Betacellulin modification
06/15/2000WO2000034477A2 Neuron-associated proteins
06/15/2000WO2000034476A2 Nucleic acid molecules of shrimp
06/15/2000WO2000034475A2 Grnf4, a gdnf-related neurotrophic factor
06/15/2000WO2000034474A2 Growth factor homolog zvegf3
06/15/2000WO2000034473A2 Seven transmembrane domain receptor zsig56
06/15/2000WO2000034472A1 Spermatogenesis protein
06/15/2000WO2000034471A1 Human neural system growing-associated genes and the proteins encoded by the genes
06/15/2000WO2000034470A1 Npcbac06: human transitional endoplasmic reticulum atpase gene
06/15/2000WO2000034468A2 Muc-1 antagonists and methods of treating immune disorders
06/15/2000WO2000034467A1 Cancer cell vaccine
06/15/2000WO2000034464A1 Method for yeast screening of protein-kinase modulators specific of superior eukaryotic cells, including human cells
06/15/2000WO2000034463A1 Formulations and methods for isolating nucleic acids from any complex starting material and subsequent complex genetic analysis
06/15/2000WO2000034462A1 Human hybrid host cell for mammalian gene expression
06/15/2000WO2000034461A2 Compositions and methods of modulating cholesterol metabolism
06/15/2000WO2000034460A1 Vectors having terminal repeat sequence of epstein-barr virus
06/15/2000WO2000034458A1 Activated cation channel of the osteoblast as a mechanism of bone anabolism
06/15/2000WO2000034457A1 Method for immobilizing oligonucleotide on a carrier
06/15/2000WO2000034456A1 Method for immobilizing dna on a carrier
06/15/2000WO2000034452A1 Glucoamylases with n-terminal extensions
06/15/2000WO2000034451A1 Treatment of pompe's disease
06/15/2000WO2000034450A1 Cutinase variants
06/15/2000WO2000034449A2 UDP-N- ACETYL GLUCOSAMINE: GALACTOSE-β1, 3-N- ACETYL GALACTOSAMINE- α-R/ N- ACETYL GLUCOSAMINE -β1, 3-N- ACETYL GALACTOSAMINE- α-R (GlcNAc TO GalNAc) β1,6-N- ACETYL GLUCOSAMINYL TRANSFERASE, C2/4GnT
06/15/2000WO2000034447A2 Human ubiquitin ligase e3 for the modulation of nf-kappa b
06/15/2000WO2000034444A2 Method and composition for preserving viruses
06/15/2000WO2000034439A1 Desaturases and methods of using them for synthesis of polyunsaturated fatty acids
06/15/2000WO2000034438A2 Method for constructing libraries of phenotypic profiles
06/15/2000WO2000034436A2 Facs assisted methods for introducing individual chromosomes into cells
06/15/2000WO2000034434A1 Multi-channel electrode arrays
06/15/2000WO2000034343A1 Method for the immobilization of oligonucleotides
06/15/2000WO2000034335A2 'death domain' containing receptors
06/15/2000WO2000034334A1 DNA ENCODING A MAMMALIAN RECEPTOR (fb41a) AND USES THEREOF
06/15/2000WO2000034330A1 Cark protein and nucleic acid molecules and uses therefor
06/15/2000WO2000034328A1 Tpaaoh04: human g protein sara gene
06/15/2000WO2000034326A1 Fluorescent proteins from non-bioluminescent species of class anthozoa, genes encoding such proteins and uses thereof
06/15/2000WO2000034320A1 Fluorescent proteins from non-bioluminiscent species of class anthozoa, genes encoding such proteins and uses thereof
06/15/2000WO2000034319A1 Fluorescent proteins from non-bioluminescent species of class anthozoa, genes encoding such proteins and uses thereof
06/15/2000WO2000034317A2 Method for reducing immunogenicity of proteins
06/15/2000WO2000034313A1 Procollagen c-proteinase inhibitors
06/15/2000WO2000034308A2 Protein transduction system and methods of use thereof
1 ... 3228 3229 3230 3231 3232 3233 3234 3235 3236 3237 3238 3239 3240 3241 3242 3243 3244 3245 3246 3247 3248 ... 4023